Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20043261HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20017750HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20038791HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20053858HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20053624HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015273HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015272HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015536HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20014966HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015563HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TCGA Plot Options
Drug Information
GeneBCL2
DrugBank IDDB05103
Drug NameAN-9
Target IDBE0000246
UniProt IDP10415
Regulation Typedownregulator
PubMed IDs11380606
CitationsRabizadeh E, Bairey O, Aviram A, Ben-Dror I, Shaklai M, Zimra Y: Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient. Eur J Haematol. 2001 Apr;66(4):263-71. doi: 10.1034/j.1600-0609.2001.066004263.x.
GroupsInvestigational
Direct ClassificationFatty acid esters
SMILESCCCC(=O)OCOC(=O)C(C)(C)C
Pathways
PharmGKB
ChEMBLCHEMBL100014